Registration

BROWN RUDNICK LLP for LUPIN PHARMACEUTICALS, INC

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 2051 - The FAST Generics Act; HR 749 - The Lower Drug Costs Through Competition Act; border adjustability tax

LobbyistCovered position, as disclosed
HENRY W MENN New COS, Sen. Bob Graham (01-04) Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commiss (93-95)

Bills named: H.R. 749 (115th), H.R. 2051 (115th)

Health Issues HCR

H.R. 2051 - The FAST Generics Act; HR 749 - The Lower Drug Costs Through Competition Act; border adjustability tax

LobbyistCovered position, as disclosed
HENRY W MENN New COS, Sen. Bob Graham (01-04) Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commiss (93-95)

Bills named: H.R. 749 (115th), H.R. 2051 (115th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
LUPIN LTD India India 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.